Starting from a selectively protected derivative of α,α′‐diaminosuberic acid ( 3 ) the linear protected peptide 11 has been obtained. Cyclisation to 12 followed by removal of the protecting groups by hydrogenolysis afforded the ‘dicarba’ analogue of oxytocin, 1 c , which showed about 5 IU/μmol of uterotonic activity in vitro .
No takes yet. Share an insight, caveat, or question.
Keller et al. (1974) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: